Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by DepartedSe7en

OTLC

Oncotelic Announces Release of Pet2DAO Tokens (PDAO)

Oncotelic Announces Release of Pet2DAO Tokens (PDAO) - Oncotelic Therapeutics...

April 5, 2023

OTLC

Oncotelic Awarded BARDA Funding for Development of OT-101

Oncotelic Awarded BARDA Funding for Development of OT-101 for long COVID...

October 17, 2022

OTLC

Oncotelic Announces Pipeline Presentation and IPO Update of

Oncotelic Announces Pipeline Presentation and IPO Update of Sapu Therapeutics...

June 15, 2022

OTLC

ONCOTELIC PROVIDES Q1 2022 FINANCIAL RESULTS COMPARED TO Q1

ONCOTELIC PROVIDES Q1 2022 FINANCIAL RESULTS COMPARED TO Q1 (globenewswire...

May 23, 2022

OTLC

Oncotelic Appoints Fatih Uckun, M.D., Ph.D., as CMO

Oncotelic Appoints Fatih Uckun, M.D., Ph.D., as Chief Medical Officer: ...

May 4, 2022

OTLC

Oncotelic Appoints Seymour Fein M.D. as CRO

Oncotelic Appoints Seymour Fein M.D. as Chief Regulatory Officer: https:...

May 4, 2022

OTLC

Oncotelic; Announcing Successful Joint Venture and Diving in

Oncotelic; Announcing Successful Joint Venture and Diving into Benefits for...

April 4, 2022

OTLC

Oncotelic presentation at MedInvest Pharmaceutical & Biotech

Oncotelic presentation at MedInvest Pharmaceutical & Biotechnology...

April 1, 2022

OTLC

Oncotelic JV Financing

Oncotelic JV Financing: https://www.youtube.com/watch?v=k0Zj59shmw0

March 21, 2022

OTLC

Oncotelic; Looking at Industry Comparison for the Company

Oncotelic; Looking at Industry Comparison for the Company: https://www...

March 15, 2022

OTLC

Oncotelic; Discussing the Company's Development Pipeline

Oncotelic; Discussing the Company's Development Pipeline: https...

March 15, 2022

OTLC

Oncotelic; Diving into the Company's Outlook for 2022

Oncotelic; Diving into the Company's Outlook for 2022: https://www...

March 15, 2022

OTLC

Oncotelic to Present New Studies on its TGF-ß Program at the

Oncotelic to Present New Studies on its TGF- Program at the American...

March 10, 2022

OTLC

Oncotelic; An Introduction to CFO Amit Shah & His Industry B

https://www.youtube.com/watch?v=D4k5OEUYvbk

March 2, 2022

OTLC

Oncotelic Initiates Phase 1 Trial Evaluating CA4P...

Oncotelic Initiates Phase 1 Trial Evaluating CA4P in Combination with...

January 5, 2022

OTLC

Oncotelic Announces that ORF8 Mutations are Driving the...

Oncotelic Announces that ORF8 Mutations are Driving the Evolution of the...

December 22, 2021

OTLC

Oncotelic’s Dr. Anthony Maida to Present at 2nd Annual TGF-β

Oncotelic’s Dr. Anthony Maida to Present at 2nd Annual TGF-β for Immuno...

December 14, 2021

OTLC

Mesothelioma Clinical Trial to Involve Drug Studied forCOVID

Mesothelioma Clinical Trial to Involve Drug Studied for COVID-19: https:...

December 8, 2021

OTLC

Oncotelic 2021 Q3 Report, Litchfield reiterates $4 12 month

Oncotelic 2021 Q3 Report, Litchfield reiterates $4 12 month PT: https://www...

December 7, 2021

OTLC

Biotech Growth Stocks Set to Benefit from Rising Volatility

https://www.benzinga.com/pressreleases/21/12/ab24422302/biotech-growth-stocks...

December 3, 2021

1 2 3 Next

Featured Company

Sonoro Energy Ltd.

Sonoro Energy Ltd. V.SNV

Sonoro Energy Ltd. is a Canada-based oil and gas company. The Company is focused on oil and gas exploration and production in ... view more »